Msn Pharmachem Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is SUMATRIPTAN USP [ROUTE CODE - "SN"], with a corresponding US DMF Number 23442.
Remarkably, this DMF maintains an Active status since its submission on January 08, 2010, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 10, 2014, and payment made on April 04, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II